Search research articles
Contact Us
Filters
Showing results (11-20 of 127) with videos related to
Page
of 13
Sort By:
Analytical Chemistry
|
November 21, 2013
Electrochemical reduction of disulfide-containing proteins for hydrogen/deuterium exchange monitored by mass spectrometry
Simon Mysling, Rune Salbo, Michael Ploug, et al.
Journal of Lipid Research
|
June 16, 2024
APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries
Ye Yang, Robert J Konrad, Michael Ploug, et al.
Nuclear Medicine and Biology
|
June 29, 2012
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts
Morten Persson, Palle Rasmussen, Jacob Madsen, et al.
Plos One
|
February 2, 2016
Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105
Karina Juhl, Anders Christensen, Morten Persson, et al.
World Journal of Clinical Oncology
|
October 11, 2014
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma
Benedikte Jacobsen, Mette Camilla Kriegbaum, Eric Santoni-Rugiu, et al.
Journal of the American Chemical Society
|
February 24, 2005
Intramolecular migration of amide hydrogens in protonated peptides upon collisional activation
Thomas J D Jørgensen, Henrik Gårdsvoll, Michael Ploug, et al.
Protein Expression and Purification
|
March 9, 2004
Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites
Henrik Gårdsvoll, Finn Werner, Leif Søndergaard, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 21, 2007
Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer
Line V Hansen, Birgit G Skov, Michael Ploug, et al.
Nuclear Medicine and Biology
|
December 17, 2011
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers
Morten Persson, Jacob Madsen, Søren Østergaard, et al.
Journal of Lipid Research
|
November 15, 2021
Expression and one-step purification of active LPL contemplated by biophysical considerations
Anne-Marie Lund Winther, Kristian Kølby Kristensen, Anni Kumari, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 127) with videos related to
Sort By:
Page
of 13
Analytical Chemistry
|
November 21, 2013
Electrochemical reduction of disulfide-containing proteins for hydrogen/deuterium exchange monitored by mass spectrometry
Simon Mysling, Rune Salbo, Michael Ploug, et al.
Journal of Lipid Research
|
June 16, 2024
APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries
Ye Yang, Robert J Konrad, Michael Ploug, et al.
Nuclear Medicine and Biology
|
June 29, 2012
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts
Morten Persson, Palle Rasmussen, Jacob Madsen, et al.
Plos One
|
February 2, 2016
Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105
Karina Juhl, Anders Christensen, Morten Persson, et al.
World Journal of Clinical Oncology
|
October 11, 2014
C4.4A as a biomarker in pulmonary adenocarcinoma and squamous cell carcinoma
Benedikte Jacobsen, Mette Camilla Kriegbaum, Eric Santoni-Rugiu, et al.
Journal of the American Chemical Society
|
February 24, 2005
Intramolecular migration of amide hydrogens in protonated peptides upon collisional activation
Thomas J D Jørgensen, Henrik Gårdsvoll, Michael Ploug, et al.
Protein Expression and Purification
|
March 9, 2004
Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites
Henrik Gårdsvoll, Finn Werner, Leif Søndergaard, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 21, 2007
Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer
Line V Hansen, Birgit G Skov, Michael Ploug, et al.
Nuclear Medicine and Biology
|
December 17, 2011
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers
Morten Persson, Jacob Madsen, Søren Østergaard, et al.
Journal of Lipid Research
|
November 15, 2021
Expression and one-step purification of active LPL contemplated by biophysical considerations
Anne-Marie Lund Winther, Kristian Kølby Kristensen, Anni Kumari, et al.
Page
of 13